Related Experiment Videos
Human endothelial cells do not exert heparin like accelerating effects on thrombin-antithrombin-complex formation
K Ruzicka1, J Wojta, O Artemiou
1Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Vienna, Austria.
Life Sciences
|November 10, 1998
Summary
Human endothelial cells (EC) do not accelerate thrombin-antithrombin complex (TAT) formation. Heparin only shows effects at high doses, and its acceleration of TAT formation inhibits the thrombomodulin-protein C system.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Thrombin-antithrombin complex (TAT) formation is a key indicator of coagulation activation.
- Endothelial cells (EC) play a crucial role in regulating hemostasis.
- The interaction between EC, thrombin, antithrombin, and heparin influences coagulation dynamics.
Purpose of the Study:
- To investigate the formation of TAT on cultured human EC and human vessel segments.
- To determine the effect of exogenous heparin on TAT formation in the presence and absence of EC.
- To assess the impact of EC-bound heparin and exogenous heparin on the thrombomodulin-protein C system.
Main Methods:
- Incubation of thrombin and antithrombin on cultured human EC and human vessel segments.
- Measurement of TAT complex formation over time.
- Assessment of EC-localized heparin activity after heparin incubation.
- Evaluation of the thrombomodulin-protein C system efficiency under various conditions.
Main Results:
- Human EC did not exhibit inherent heparin-like acceleration of TAT formation.
- Exogenous heparin accelerated TAT formation, with maximal levels reached rapidly.
- Significant EC-localized heparin activity was observed only at very high heparin doses.
- Acceleration of TAT formation by heparin significantly reduced the efficiency of the thrombomodulin-protein C system.
Conclusions:
- Human EC do not possess intrinsic heparin-like properties that accelerate TAT formation.
- EC-localized heparin activity requires supra-therapeutic doses of heparin.
- Heparin-induced acceleration of TAT formation at the EC surface effectively inhibits the thrombomodulin-protein C anticoagulant pathway.